These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23903252)

  • 1. Helping men make decisions about PSA tests.
    BMJ; 2013 Jul; 347():f4785. PubMed ID: 23903252
    [No Abstract]   [Full Text] [Related]  

  • 2. PSA screening: the USPSTF got it right.
    Lefevre M
    J Fam Pract; 2013 Nov; 62(11):617, 619. PubMed ID: 24288702
    [No Abstract]   [Full Text] [Related]  

  • 3. PSA screening: the USPSTF got it wrong.
    Scherger JE
    J Fam Pract; 2013 Nov; 62(11):616, 618. PubMed ID: 24288701
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new PSA report: understand the controversy.
    Harv Mens Health Watch; 2012 Feb; 16(7):1-4. PubMed ID: 22474703
    [No Abstract]   [Full Text] [Related]  

  • 6. Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millennium.
    Djavan B
    Eur Urol; 2010 Jun; 57(6):928-9. PubMed ID: 20304552
    [No Abstract]   [Full Text] [Related]  

  • 7. New PSA guidelines discourage overscreening.
    Peres J
    J Natl Cancer Inst; 2012 Jan; 104(1):8-9. PubMed ID: 22173585
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen dynamics and prostate cancer diagnosis.
    Bartoletti R
    Eur Urol; 2009 Nov; 56(5):761-2; discussion 763. PubMed ID: 19665286
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [When and how to prescribe PSA?].
    Coloby P
    Rev Prat; 2013 Apr; 63(4):476-7. PubMed ID: 23682471
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
    Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: optimization of PSA screening policies: a comparison of the patient and societal perspectives.
    Penson DF
    J Urol; 2013 Feb; 189(2):529-30. PubMed ID: 23312159
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Free' prostate cancer screens can be costly.
    Consum Rep; 2011 May; 76(5):12. PubMed ID: 21513002
    [No Abstract]   [Full Text] [Related]  

  • 15. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
    Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
    Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an optimal prostate-specific antigen threshold for prostate biopsy?
    Stephan C; Miller K; Jung K
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1215-21. PubMed ID: 21916575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death knell for PSA screening?
    Mani H
    Natl Med J India; 2011; 24(6):380. PubMed ID: 22680272
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer: is the PSA test the answer?
    Berlin B
    N J Med; 1998 Mar; 95(3):53-5. PubMed ID: 16013148
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer screening.
    Sikaris K
    Pathology; 2012 Feb; 44(2):99-109. PubMed ID: 22198258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.